Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
126 studies found for:    Open Studies | "Skin Diseases, Infectious"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Human Immunity Against Staphylococcus Aureus Skin Infection
Condition: Staphylococcus Aureus Skin Infection
Intervention: Other: Killed Bacteria
2 Not yet recruiting Study of Tedizolid Phosphate in Adolescents With cSSTI.
Conditions: Skin Diseases, Infectious;   Skin Diseases, Bacterial
Interventions: Drug: Tedizolid Phophate 200 mg, IV to oral for 6 days;   Drug: Antibiotic comparator
3 Recruiting Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
4 Recruiting Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Conditions: Acute Bacterial Skin Infection;   Skin Structure Infection
Interventions: Drug: delafloxacin;   Drug: vancomycin
5 Recruiting ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)
Condition: Skin Infections, Bacterial
Intervention: Drug: ALTARGO(retapamulin)
6 Recruiting Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment
Conditions: Late Complication From Skin Graft;   Infection of Skin Donor Site;   Impaired Wound Healing;   Pain, Intractable
Intervention: Device: Sericin scaffold
7 Recruiting Efficacy and Safety of Silk Fibroin With Bioactive Coating Layer Dressing
Conditions: Late Complication From Skin Graft;   Infection of Skin Donor Site;   Impaired Wound Healing;   Pain, Intractable;   Transepidermal Water Loss (TEWL)
Interventions: Device: Silk fibroin with bioactive coating layer dressing;   Device: Bactigras wound dressing
8 Recruiting Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital
Condition: Cellulitis
Interventions: Other: Home;   Other: Ward;   Drug: ceftriaxone;   Drug: flucloxacillin
9 Recruiting Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
Conditions: Skin Diseases, Bacterial;   Abscess
Interventions: Biological: Linezolid;   Biological: Clindamycin
10 Not yet recruiting Use of Corticosteroids in Children With Cellulitis
Condition: Cellulitis
Interventions: Drug: Dexamethasone;   Drug: Normal Saline
11 Recruiting Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis
Condition: Cellulitis
Interventions: Drug: Prednisone;   Drug: Placebo
12 Recruiting Duration of ANtibiotic Therapy for CEllulitis
Conditions: Cellulitis;   Erysipelas
Interventions: Drug: Flucloxacillin;   Drug: Placebo (for flucloxacillin)
13 Unknown † Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females
Conditions: Tinea Pedis;   Athlete's Foot;   Foot Fungus;   Ringworm
Intervention: Drug: Sertaconazole  nitrate  cream 2%
14 Recruiting The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
Condition: Impetigo
Interventions: Drug: papaya 1% extract ointment;   Drug: mupirocin 2% ointment
15 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
16 Unknown † Citriodiol® and Impetigo
Condition: Impetigo
Intervention: Drug: p-menthane-3,8-diol oil
17 Recruiting Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
18 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
19 Recruiting Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
Condition: Impetigo
Interventions: Drug: Ozenoxacin;   Drug: Placebo
20 Not yet recruiting Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana
Condition: Onchocerciasis
Interventions: Drug: IVM plus ALB;   Drug: IVM
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years